Y-Biologics, Inc
Develops antibody-based therapeutics for cancer, focusing on immuno-oncology.
338840 | KO
Overview
Corporate Details
- ISIN(s):
- KR7338840002
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크로 4로 17, 비715호, 대전광역시
- Website:
- https://ybiologics.com/en/
Description
Y-Biologics, Inc. is a biotechnology company specializing in the discovery and development of novel antibody-based therapeutics. The company's primary focus is on immuno-oncology, where it develops next-generation multispecific antibodies for the treatment of cancer. Y-Biologics leverages its proprietary human antibody discovery platform to advance its internal pipeline and support collaborations through technology transfers and joint development partnerships.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-19 00:00 |
감사보고서 (2021.12)
|
Korean | 392.9 KB | ||
| 2021-04-01 00:00 |
감사보고서 (2020.12)
|
Korean | 368.3 KB | ||
| 2020-04-07 00:00 |
감사보고서 (2019.12)
|
Korean | 369.1 KB | ||
| 2019-04-15 00:00 |
감사보고서 (2018.12)
|
Korean | 364.8 KB |
Automate Your Workflow. Get a real-time feed of all Y-Biologics, Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Y-Biologics, Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Y-Biologics, Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
